Broker Regulation

Treatments for rare diseases brought in $114 billion in worldwide sales last year and drugmakers big and small are increasingly banking on them to boost revenue.

Researchers from the University of Pennsylvania analyzed data on 23,442 oncologists in the U.S., evaluating how often doctors affiliated with National Cancer Institute-designated centers were covered by lower-cost insurance plans.

Here's a look at the number of insurance producer fines in each state -- and the number of producer-related cases involving restitution.

The president's new health care strategy of repeal minus fast replacement ratchets up uncertainty once again.

We asked brokers about the Trump administration, sales strategies, the ACA marketplace, and what they think is coming down the pipeline. Here is what they had to say.

An Obamacare fund that Republicans criticized as a "bailout" of insurance companies has resurfaced as a similar provision in the Senate GOPs health care plan -- though this time the objections are more muted.